Robert R Ruffolo's Net Worth
$5.71 Million
Who is Robert R Ruffolo?
Robert R Ruffolo has an estimated net worth of $5.71 Million. This is based on reported shares across multiple companies, which include Aridis Pharmaceuticals, Inc., Diffusion Pharmaceuticals Inc., WYETH, Sigilon Therapeutics, Inc., and Elicio Therapeutics, Inc..
SEC CIK
Robert R Ruffolo's CIK is 0001187308
Past Insider Trading and Trends
2006 was Robert R Ruffolo's most active year for acquiring shares with 3 total transactions. Robert R Ruffolo's most active month to acquire stocks was the month of March. 2006 was Robert R Ruffolo's most active year for disposing of shares, totalling 5 transactions. Robert R Ruffolo's most active month to dispose stocks was the month of October. 2007 saw Robert R Ruffolo paying a total of $5,248,157.80 for 240,436 shares, this is the most they've acquired in one year. In 2007 Robert R Ruffolo cashed out on 261,636 shares for a total of $7,644,770.58, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aridis Pharmaceuticals, Inc. (ARDS) Snapshot price: $0.064
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Diffusion Pharmaceuticals Inc. (CRVO) Snapshot price: $14.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
WYETH No price found
Sr. VP & Pres., Wyeth Research
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 29.67K |
$42.54 | -$874,197.00 | 29.67K |
Feb 29
| |||
Form 4
| -100.00% | -764.00 |
$47.78 | -$36,503.92 |
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
$49.29 | -$2,360,108.86 | 30K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
| +80.79% | 93.77K |
$50.64 | -$123,105.84 | 209.84K |
Feb 26
| |||
Form 4
| +1.08% | 1.24K |
$51.65 | -$1,446.20 | 116.07K |
Jan 25
| |||
Form 4
|
—
|
0
|
$44.71 | -$1,817,203.25 |
0
|
Oct 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
| +495.04% | 93.95K |
$48.97 | -$110,269.18 | 112.93K |
Feb 27
| |||
Form 4
| -100.00% | -15.58K |
$46.17 | -$719,318.52 |
0
|
Feb 10
| |||
Form 4
| +7.00% | 1.24K |
$46.83 | -$1,404.75 | 18.98K |
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
| +38.67% | 4.85K |
$40.63 | -$9,669.94 | 17.38K |
Mar 3
| |||
Form 4
| +116.12% | 22.91K |
$44.51 | -$315,787.37 | 42.63K |
Nov 19 - Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 4/A
|
∞
| 5.08K |
—
|
—
| 5.08K |
Jan 27
| |||
Form 4
|
∞
| 4.97K |
$41.65 | -$4,955.75 | 4.97K |
Jan 27
| |||
| No matching records found | |||||||||
Sigilon Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
$5.47 | -$66,082.50 |
0
|
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Elicio Therapeutics, Inc. (ELTX) Snapshot price: $3.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||